HIV treatment as prevention: Systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa

PLoS Medicine

Volumn 9, Issue 7, 2012, Pages

  Eaton, Jeffrey W ^a   Johnson, Leigh F ^b   Salomon, Joshua A ^c   Bärnighausen, Till ^c,d   Bendavid, Eran ^e   Bershteyn, Anna ^f   Bloom, David E ^c   Cambiano, Valentina ^g   Fraser, Christophe ^a   Hontelez, Jan A C ^d,h,i   Humair, Salal ^c,j   Klein, Daniel J ^f   Long, Elisa F ^k   Phillips, Andrew N ^g   Pretorius, Carel ^l   Stover, John ^l   Wenger, Edward A ^f   Williams, Brian G ^m   Hallett, Timothy B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Intellectual Ventures Laboratory   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j LAHORE UNIVERSITY OF MANAGEMENT SCIENCES   (Pakistan)

^k YALE UNIVERSITY   (United States)

^l AVENIR HEALTH   (United States)

^m STELLENBOSCH UNIVERSITY   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION RATE; INFECTION RISK; MATHEMATICAL MODEL; POPULATION STRUCTURE; PREDICTION; SIMULATION; SOUTH AFRICA; VIRUS TRANSMISSION; ADULT; BIOLOGICAL MODEL; COMPARATIVE STUDY; COMPUTER SIMULATION; HEALTH CARE PLANNING; IMMUNOLOGY; PHYSIOLOGY; PREVALENCE; STATISTICS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMPUTER SIMULATION; HEALTH PLANNING; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; MODELS, BIOLOGICAL; PREVALENCE; SOUTH AFRICA;

EID: 84864475438     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001245     Document Type: Article

References (84)

1. Montaner JSG, Hogg R, Wood E, Kerr T, Tyndall M, et al. (2006) The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368: 531-536 doi:10.1016/S0140-6736(06)69162-9.
2. De Cock KM, Gilks CF, Lo Y-R, Guerma T, (2009) Can antiretroviral therapy eliminate HIV transmission? Lancet 373: 7-9 doi:10.1016/S0140-6736(08)61732-8.
3. Garnett GP, Baggaley RF, (2009) Treating our way out of the HIV pandemic: could we, would we, should we? Lancet 373: 9-11 doi:10.1016/S0140-6736(08)61698-0.
4. Cohen J, (2011) Halting HIV/AIDS epidemics. Science 334: 1338-1340.
5. Granich R, Gupta S, Suthar A, Smyth C, Hoos D, et al. (2011) Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res 9: 446-469 doi:10.2174/157016211798038597.
6. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342: 921-929 doi:10.1056/NEJM200003303421303.
7. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP, (2007) Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A 104: 17441-17446 doi:10.1073/pnas.0708559104.
8. Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, et al. (2000) Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 14: 117-121.
9. Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, et al. (2000) Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 14: 415-421.
10. Baggaley RF, Ferguson NM, Garnett GP, (2005) The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol 2: 9 doi:10.1186/1742-7622-2-9.
11. Dodd PJ, Garnett GP, Hallett TB, (2010) Examining the promise of HIV elimination by "test and treat" in hyperendemic settings. AIDS 24: 729-735 doi:10.1097/QAD.0b013e32833433fe.
12. Anderson RM, Gupta S, May RM, (1991) Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1. Nature 350: 356-359 doi:10.1038/350356a0.
13. Gilliam BL, Dyer JR, Fiscus SA, Marcus C, Zhou S, et al. (1997) Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. J Acquir Immune Defic Syndr Hum Retrovirol 15: 54-60.
14. Blower SM, Gershengorn HB, Grant RM, (2000) A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 287: 650-654.
15. Dangerfield BC, Fang Y, Roberts CA, (2001) Model-based scenarios for the epidemiology of HIV/AIDS: the consequences of highly active antiretroviral therapy. Syst Dyn Rev 17: 119-150 doi:10.1002/sdr.211.
16. Law MG, Prestage G, Grulich A, Van de Ven P, Kippax S, (2001) Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 15: 1287-1294.
17. Velasco-Hernandez JX, Gershengorn HB, Blower SM, (2002) Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2: 487-493 doi:10.1016/S1473-3099(02)00346-8.
18. Xiridou M, Geskus R, De Wit J, Coutinho R, Kretzschmar M, (2003) The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS 17: 1029-1038 doi:10.1097/01.aids.0000050879.72891.1d.
19. Gray RH, Li X, Wawer MJ, Gange SJ, Serwadda D, et al. (2003) Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17: 1941-1951 doi:10.1097/01.aids.0000076313.76477.fc.
20. Blower S, Bodine E, Kahn J, McFarland W, (2005) The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS 19: 1-14.
21. Baggaley RF, Garnett GP, Ferguson NM, (2006) Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med 3: e124 doi:10.1371/journal.pmed.0030124.
22. McCormick AW, Walensky RP, Lipsitch M, Losina E, Hsu H, et al. (2007) The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis 44: 1115-1122 doi:10.1086/512816.
23. Salomon JA, Hogan DR, (2008) Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS 22 (Suppl 1): S149-S159 doi:10.1097/01.aids.0000327636.82542.87.
24. Attia S, Egger M, Müller M, Zwahlen M, Low N, (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23: 1397-1404 doi:10.1097/QAD.0b013e32832b7dca.
25. Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, et al. (2011) HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS 25: 473-477 doi:10.1097/QAD.0b013e3283437c2b.
26. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al. (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092-2098 doi:10.1016/S0140-6736(10)60705-2.
27. Glynn JR, Price A, Floyd S, Molesworth A, Kayuni N, et al. (2011) Anitretroviral therapy reduces HIV transmission in discordant couples in northern Malawi. Sex Transm Infect 87: A218 doi:10.1136/sextrans-2011-050108.277.
28. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505 doi:10.1056/NEJMoa1105243.
29. Lodwick R, Costagliola D, Reiss P, Torti C, Teira R, et al. (2010) Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Arch Intern Med 170: 410-419 doi:10.1001/archinternmed.2009.472.
30. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, et al. (2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 24: 563-572 doi:10.1097/QAD.0b013e328333bfb7.
31. Nash D, Katyal M, Brinkhof MWG, Keiser O, May M, et al. (2008) Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 22: 2291-2302 doi:10.1097/QAD.0b013e3283121ca9.
32. Joint United Nations Programme on HIV/AIDS (2010) Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Available: http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf. Accessed 19 December 2011.
33. Joint United Nations Programme on HIV/AIDS (2011) World AIDS Day Report 2011. How to get to zero: faster, smarter, better. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2216_WorldAIDSday_report_2011_en.pdf. Accessed 23 December 2011.
34. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57 doi:10.1016/S0140-6736(08)61697-9.
35. Wagner BG, Blower S, (2009) Voluntary universal testing and treatment is unlikely to lead to HIV elimination: a modeling analysis. doi:10.1038/npre.2009.3917.1.
36. Kretzschmar ME, van der Loeff MF, Coutinho RA, (2012) Elimination of HIV by test and treat. AIDS 26: 247-248 doi:10.1097/QAD.0b013e32834e1592.
37. Bacaër N, Pretorius C, Auvert B, (2010) An age-structured model for the potential impact of generalized access to antiretrovirals on the South African HIV epidemic. Bull Math Biol 72: 2180-2198 doi:10.1007/s11538-010-9535-2.
38. Bendavid E, Brandeau ML, Wood R, Owens DK, (2010) Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med 170: 1347-1354 doi:10.1001/archinternmed.2010.249.
39. World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision. Available: http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf. Accessed 22 December 2011.
40. PEPFAR Scientific Advisory Board (2011) PEPFAR Scientific Advisory Board recommendations for the Office of the US Global AIDS Coordinator: implications of HPTN 052 for PEPFAR's treatment programs. Available: http://www.pepfar.gov/documents/organization/177126.pdf. Accessed 19 December 2011.
41. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, et al. (2011) Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 377: 2031-2041 doi:10.1016/S0140-6736(11)60702-2.
42. Hontelez JA, de Vlas SJ, Tanser F, Bakker R, Bärnighausen T, et al. (2011) The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS ONE 6: e21919 doi:10.1371/journal.pone.0021919.
43. Johnson LF, Hallett TB, Rehle TM, Dorrington RE, (2012) The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface 9: 1544-1554 doi:10.1098/rsif.2011.0826.
44. Boily MC, Mâsse B, Alsallaq R, Padian NS, Eaton JW, et al. (2012) HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med 9: e1001250 doi:10.1371/journal.pmed.1001250.
45. Johnson LF, (2012) Access to antiretroviral treatment in South Africa, 2004-2011. South Afr J HIV Med 13: 22-27.
46. South Africa National AIDS Council (2011) National strategic plan on HIV, STIs and TB: 2012-2016 summary. Available: http://www.doh.gov.za/docs/stratdocs/2012/NSPsum.pdf. Accessed 25 May 2012.
47. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, et al. (2009) South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide amongst teenagers? Cape Town HSRC Press.
48. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat (2011) World population prospects: the 2010 revision. Available: http://esa.un.org/unpd/wpp/index.htm. Accessed 19 December 2011.
49. The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group (2012) HIV treatment as prevention: models, data, and questions-Towards evidence-based decision-making. PLoS Med 9: e1001259 doi:10.1371/journal.pmed.1001259.
50. Anderson RM, May RM, (1992) Infectious diseases of humans: dynamics and control Oxford Oxford University Press.
51. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention (2009) Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med 6: e1000109 doi:10.1371/journal.pmed.1000109.
52. Hankins CA, Glasser JW, Chen RT, (2011) Modeling the impact of RV144-like vaccines on HIV transmission. Vaccine 29: 6069-6071 doi:10.1016/j.vaccine.2011.07.001.
53. Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DA, et al. (2008) Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A 105: 4639-4644 doi:10.1073/pnas.0706849105.
54. Althaus CL, Turner KM, Schmid BV, Heijne JC, Kretzschmar M, et al. (2011) Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data. J R Soc Interface 9: 136-146 doi:10.1098/rsif.2011.0131.
55. Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, et al. (2005) Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral-naive and-experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDS 19: 760-768.
56. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, et al. (2006) Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 20: 85-92.
57. Eisele TP, Mathews C, Chopra M, Lurie MN, Brown L, et al. (2009) Changes in risk behavior among HIV-positive patients during their first year of antiretroviral therapy in Cape Town South Africa. AIDS Behav 13: 1097-1105 doi:10.1007/s10461-008-9473-2.
58. McClelland RS, Graham SM, Richardson BA, Peshu N, Masese LN, et al. (2010) Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers. AIDS 24: 891-897 doi:10.1097/QAD.0b013e32833616c7.
59. Venkatesh KK, de Bruyn G, Lurie MN, Mohapi L, Pronyk P, et al. (2010) Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS 24: 2687-2696 doi:10.1097/QAD.0b013e32833e78d4.
60. Venkatesh KK, Flanigan TP, Mayer KH, (2011) Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world. AIDS 25: 1939-1949 doi:10.1097/QAD.0b013e32834b4ced.
61. Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, et al. (2008) A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 22: 1071-1077 doi:10.1097/QAD.0b013e3282fd167c.
62. Smith MK, Powers KA, Muessig KE, Miller WC, Cohen MS, (2012) HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med 9: e1001260 doi:10.1371/journal.pmed.1001260.
63. Wilson DP, (2012) HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Med 9: e1001231 doi:10.1371/journal.pmed.1001231.
64. Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM, (2010) Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis 10: 155-166 doi:10.1016/S1473-3099(09)70328-7.
65. Vardavas R, Blower S, (2007) The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?" PLoS ONE 2: e152 doi:10.1371/journal.pone.0000152.
66. Phillips AN, Pillay D, Garnett G, Bennett D, Vitoria M, et al. (2011) Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS 25: 843-850 doi:10.1097/QAD.0b013e328344037a.
67. Wagner BG, Kahn JS, Blower S, (2010) Should we try to eliminate HIV epidemics by using a "Test and Treat" strategy? AIDS 24: 775-776 doi:10.1097/QAD.0b013e3283366782.
68. Boily M-C, Baggaley RF, Wang L, Masse B, White RG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9: 118-129 doi:10.1016/S1473-3099(09)70021-0.
69. Hollingsworth TD, Anderson RM, Fraser C, (2008) HIV-1 transmission, by stage of infection. J Infect Dis 198: 687-693 doi:10.1086/590501.
70. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191: 1403-1409 doi:10.1086/429411.
71. Cohen MS, Dye C, Fraser C, Miller WC, Powers KA, et al. (2012) HIV treatment as prevention: debate and commentary-will early infection compromise treatment-as-prevention strategies? PLoS Med 9: e1001232 doi:10.1371/journal.pmed.1001232.
72. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, et al. (2011) The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 78: 256-268 doi:10.1016/S0140-6736(11)60842-8.
73. Rosen S, Fox MP, (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 8: e1001056 doi:10.1371/journal.pmed.1001056.
74. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24: 2263-2270 doi:10.1097/QAD.0b013e32833d45c5.
75. The US President's Emergency Plan for AIDS Relief (2011 August) Guidance for the prevention of sexually transmitted HIV infections. Available: http://www.pepfar.gov/documents/organization/171303.pdf. Accessed 19 March 2012.
76. Maher D, Biraro S, Hosegood V, Isingo R, Lutalo T, et al. (2010) Translating global health research aims into action: the example of the ALPHA network. Trop Med Int Health 15: 321-328 doi:10.1111/j.1365-3156.2009.02456.x.
77. Stover J, Bollinger L, Avila C, (2011) Estimating the impact and cost of the WHO 2010 recommendations for antiretroviral therapy. AIDS Res Treat 2011: 738271 doi:10.1155/2011/738271.
78. Stover J, Johnson P, Hallett T, Marston M, Becquet R, et al. (2010) The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect 86 (Suppl 2): ii16-ii21 doi:10.1136/sti.2010.044222.
79. Tanser F, Hosegood V, Bärnighausen T, Herbst K, Nyirenda M, et al. (2008) Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 37: 956-962 doi:10.1093/ije/dym211.
80. AIDS 2031 Commission (2010) AIDS in an uncertain world: the report of the AIDS 2031 Commission Upper Saddle River (New Jersey) Prentice Hall.
81. Long E, Brandeau M, (2010) The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med 158: 778-789.
82. Hontelez JA, Lurie MN, Newell ML, Bakker R, Tanser F, et al. (2011) Ageing with HIV in south africa. AIDS 25: 1665-1667 doi:10.1097/QAD.0b013e32834982ea.
83. Hontelez JA, Nagelkerke N, Bärnighausen T, Bakker R, Tanser F, et al. (2011) The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine 29: 6100-6106 doi:10.1016/j.vaccine.2011.06.059.
84. Johnson L, Dorrington R, Bradshaw D, Pillay-Van Wyk V, Rehle T, (2009) Sexual behaviour patterns in South Africa and their association with the spread of HIV: insights from a mathematical model. Demogr Res 21: 289-340 doi:10.4054/DemRes.2009.21.11.